EGD vs EUS in Diagnosing Portal Hypertension in Cirrhotic Patients.
A Randomized Controlled Trial Comparing Endoscopic Ultrasound Evaluation Versus Esophagogastroduodenoscopy in the Diagnosis of Portal Hypertension in Cirrhotic Patients
1 other identifier
interventional
35
1 country
1
Brief Summary
Liver cirrhosis with the further development of portal hypertension implies structural and vasculature alteration in the portosplenic circulation. Esophagogastroduodenoscopy is the standard of care for the detection and treatment of esophageal varices, as esophageal varices serve as a surrogate for estimating a portal pressure gradient \> 10 mmHG. Endoscopic ultrasound evaluation allows the detection of peri-esophageal collateral veins, perforating veins and para-esophageal collateral veins, which has demonstrated to be effective for the prediction of esophageal varices recurrence after variceal eradication. The investigators aimed to compare esophagogastroduodenoscopy versus endoscopic ultrasound evaluation for the early diagnosis of portal hypertension in cirrhotic patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2019
CompletedFirst Submitted
Initial submission to the registry
November 7, 2019
CompletedFirst Posted
Study publicly available on registry
December 9, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2020
CompletedDecember 9, 2019
December 1, 2019
1 year
November 7, 2019
December 5, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Diagnosis of portal hypertension
Portal hypertension diagnosis based on portal pressure gradient
During portal pressure gradient meassurement up to 4 weeks after randomization
Secondary Outcomes (2)
diagnostic accuracy of esophagogastroduodenoscopy
during esophagogastroduodenoscopy procedure up to 2 weeks after randomization
diagnostic accuracy of endoscopic ultrasound
during endoscopic ultrasound evaluation up yo 2 weeks after randomization
Study Arms (2)
EGD evaluation
PLACEBO COMPARATOREsophogagastroduodenoscopy for the evaluation of esophageal varices, gastric varices and hypertensive gastropathy. Portal pressure gradient will be evaluated via interventional radiology as gold standard.
EUS evaluation
EXPERIMENTALEndoscopic ultrasound evaluation for the presence of esophageal varices, peri and para-esophageal collateral veins, gastric varices, portal hypertensive gastropathy, azygos vein diameter, blood flow and BFVI. Portal pressure gradient will be evaluated via interventional radiology as gold standard.
Interventions
Esophogagastroduodenoscopy for the evaluation of esophageal varices, gastric varices and hypertensive gastropathy. Portal pressure gradient will be evaluated via interventional radiology as gold standard.
Endoscopic ultrasound evaluation for the presence of esophageal varices, peri and para-esophageal collateral veins, gastric varices, portal hypertensive gastropathy, azygos vein diameter, blood flow and BFVI. Portal pressure gradient will be evaluated via interventional radiology as gold standard.
Eligibility Criteria
You may qualify if:
- Above 18 years old
- Willingness to participate in the study
- Compensated liver cirrhosis based on clinical and imaging findings
- Written informed consent provided
You may not qualify if:
- Decompensated liver cirrhosis: ascitis, encephalopathy, gastrointestinal bleeding, infection
- Hemodynamic instability
- Pregant or nursing patients
- Patients with history of esophageal, gastric, liver, pancreas and spleen tumors
- Severe uncontrolled coagulopathy
- Any contraindication for portal pressure gradient meassurement via radiological evaluation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ecuadorian Institute of Digestive Diseases
Guayaquil, Guayas, 090505, Ecuador
Related Publications (2)
Boustiere C, Dumas O, Jouffre C, Letard JC, Patouillard B, Etaix JP, Barthelemy C, Audigier JC. Endoscopic ultrasonography classification of gastric varices in patients with cirrhosis. Comparison with endoscopic findings. J Hepatol. 1993 Sep;19(2):268-72. doi: 10.1016/s0168-8278(05)80581-1.
PMID: 8301060BACKGROUNDHammoud GM, Ibdah JA. Utility of endoscopic ultrasound in patients with portal hypertension. World J Gastroenterol. 2014 Oct 21;20(39):14230-6. doi: 10.3748/wjg.v20.i39.14230.
PMID: 25339809BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 7, 2019
First Posted
December 9, 2019
Study Start
November 1, 2019
Primary Completion
November 1, 2020
Study Completion
November 30, 2020
Last Updated
December 9, 2019
Record last verified: 2019-12
Data Sharing
- IPD Sharing
- Will not share